161 related articles for article (PubMed ID: 17366531)
21. Clinical characteristics and treatment outcome of infants with non-Hodgkin lymphoma.
Mann G; Attarbaschi A; Burkhardt B; Niggli F; Klapper W; Ludwig WD; Schrappe M; Zimmermann M; Gadner H; Reiter A;
Br J Haematol; 2007 Nov; 139(3):443-9. PubMed ID: 17868047
[TBL] [Abstract][Full Text] [Related]
22. [Intensive chemotherapy in Burkitt's lymphoma and aggressive non-Hodgkin's lymphoma].
Holte H; Smeland S; Blystad AK; Kvaløy S; Hammerstrøm J; Tjønnfjord GE
Tidsskr Nor Laegeforen; 2002 Feb; 122(4):364-9. PubMed ID: 11915663
[TBL] [Abstract][Full Text] [Related]
23. [Efficacy of modified B-NHL-BFM-90 protocol on Burkitt's lymphoma in Chinese children and adolescents].
Sun XF; Zhen ZJ; Liu DG; Xia Y; Xiang XJ; Chen XQ; Ling JY; Zheng L; Luo WB; Lin H; He YJ; Guan ZZ
Ai Zheng; 2007 Dec; 26(12):1339-43. PubMed ID: 18076797
[TBL] [Abstract][Full Text] [Related]
24. Secondary non-Hodgkin lymphoma (NHL) in children and adolescents after childhood cancer other than NHL.
Landmann E; Oschlies I; Zimmermann M; Moser O; Graf N; Suttorp M; Greiner J; Reiter A;
Br J Haematol; 2008 Nov; 143(3):387-94. PubMed ID: 18729852
[TBL] [Abstract][Full Text] [Related]
25. Promising therapy results for lymphoid malignancies in children with chromosomal breakage syndromes (Ataxia teleangiectasia or Nijmegen-breakage syndrome): a retrospective survey.
Bienemann K; Burkhardt B; Modlich S; Meyer U; Möricke A; Bienemann K; Mauz-Körholz C; Escherich G; Zimmermann M; Körholz D; Janka-Schaub G; Schrappe M; Reiter A; Borkhardt A
Br J Haematol; 2011 Nov; 155(4):468-76. PubMed ID: 21923652
[TBL] [Abstract][Full Text] [Related]
26. Comparison of treatment outcomes of childhood Hodgkin lymphoma in two US centers and a center in Recife, Brazil.
Hsu SC; Metzger ML; Hudson MM; Pedrosa F; Lins M; Pedrosa M; Barros C; Maciel K; Pui CH; Ribeiro RC; Howard SC
Pediatr Blood Cancer; 2007 Aug; 49(2):139-44. PubMed ID: 16642484
[TBL] [Abstract][Full Text] [Related]
27. Non-Hodgkin lymphoma (NHL) in children with Nijmegen Breakage syndrome (NBS).
Dembowska-Baginska B; Perek D; Brozyna A; Wakulinska A; Olczak-Kowalczyk D; Gladkowska-Dura M; Grajkowska W; Chrzanowska KH
Pediatr Blood Cancer; 2009 Feb; 52(2):186-90. PubMed ID: 18937313
[TBL] [Abstract][Full Text] [Related]
28. Primary localized stages I and II non-Hodgkin's lymphoma of the nasopharynx: a retrospective 17-year single institutional experience.
Mohammadianpanah M; Ahmadloo N; Mozaffari MA; Mosleh-Shirazi MA; Omidvari S; Mosalaei A
Ann Hematol; 2009 May; 88(5):441-7. PubMed ID: 18931844
[TBL] [Abstract][Full Text] [Related]
29. Treating childhood acute myeloid leukaemia with the AML-BFM-83 protocol: experience in a developing country.
Chan LL; Abdel-Latif ME; Ariffin WA; Ariffin H; Lin HP
Br J Haematol; 2004 Sep; 126(6):799-805. PubMed ID: 15352983
[TBL] [Abstract][Full Text] [Related]
30. AIDS and non-Hodgkin's lymphoma. Experience at an oncological center in Mexico.
Cornejo-Juárez P; Volkow-Fernández P; Avilés-Salas A; Calderón-Flores E
Rev Invest Clin; 2008; 60(5):375-81. PubMed ID: 19227434
[TBL] [Abstract][Full Text] [Related]
31. Non-Hodgkin lymphoma in children and adolescents.
Reiter A
Klin Padiatr; 2013 May; 225 Suppl 1():S87-93. PubMed ID: 23700066
[TBL] [Abstract][Full Text] [Related]
32. Poor outcome for children and adolescents with progressive disease or relapse of lymphoblastic lymphoma: a report from the berlin-frankfurt-muenster group.
Burkhardt B; Reiter A; Landmann E; Lang P; Lassay L; Dickerhoff R; Lakomek M; Henze G; von Stackelberg A
J Clin Oncol; 2009 Jul; 27(20):3363-9. PubMed ID: 19433688
[TBL] [Abstract][Full Text] [Related]
33. [CEOP regimen in the treatment for non-Hodgkin's lymphoma].
Huang HQ; Lin XB; Pan ZH; Bu Q; Gao Y; Wang BF; Cai QQ; Xia ZJ; Xu RH; Jiang WQ; Guan ZZ
Zhonghua Zhong Liu Za Zhi; 2007 May; 29(5):391-5. PubMed ID: 17892140
[TBL] [Abstract][Full Text] [Related]
34. Treatment of pediatric non-Hodgkin lymphomas in a country with limited resources: results of the first national protocol in Nicaragua.
Baez F; Pillon M; Manfredini L; Ocampo E; Mendez G; Ortiz R; Palacios R; Gutierrez T; Tridello G; Conter V; Valsecchi M; Fossati Bellani F; Cavalli F; Masera G; Rosolen A
Pediatr Blood Cancer; 2008 Jan; 50(1):148-52. PubMed ID: 16972240
[TBL] [Abstract][Full Text] [Related]
35. Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.
Attarbaschi A; Mann G; Panzer-Grümayer R; Röttgers S; Steiner M; König M; Csinady E; Dworzak MN; Seidel M; Janousek D; Möricke A; Reichelt C; Harbott J; Schrappe M; Gadner H; Haas OA
J Clin Oncol; 2008 Jun; 26(18):3046-50. PubMed ID: 18565891
[TBL] [Abstract][Full Text] [Related]
36. [Treatment results in children with the standard risk acute lymphoblastic leukemia treated with high dose of methotrexate (5.0 g/m2). 11 years of the Polish Pediatric Leukemia/Lymphoma Study Group experience].
Derwich K; Wachowiaki J; Kaczmarek-Kanoldi M; Balcerska A; Balwierz W; Chybicka A; Kowalczyk JR; Matysiak M; Jackowska T; Sońta-Jakimczyk D; Wysocki M; Chełmecka-Hanuszewicz L; Cwiklińska M; Kołtan A; Malinowska I; Odój T; Płoszyńska A; Steczowicz M; Wojciechowska V; Wójtowicz A;
Przegl Lek; 2006; 63(1):7-10. PubMed ID: 16892891
[TBL] [Abstract][Full Text] [Related]
37. Should children with non-Hodgkin lymphoma be treated with different protocols according to histopathologic subtype?
Lee SH; Yoo KH; Sung KW; Ko YH; Lee JW; Koo HH
Pediatr Blood Cancer; 2013 Nov; 60(11):1842-7. PubMed ID: 23857875
[TBL] [Abstract][Full Text] [Related]
38. Time-dependent effect of non-Hodgkin's lymphoma grade on disease-free survival of relapsed/refractory patients treated with high-dose chemotherapy plus autotransplantation.
Fu P; van Heeckeren WJ; Wadhwa PD; Bajor DJ; Creger RJ; Xu Z; Cooper BW; Laughlin MJ; Gerson SL; Koç ON; Lazarus HM
Contemp Clin Trials; 2008 Mar; 29(2):157-64. PubMed ID: 17707140
[TBL] [Abstract][Full Text] [Related]
39. Non-anaplastic peripheral T-cell lymphoma in children and adolescents--a retrospective analysis of the NHL-BFM study group.
Kontny U; Oschlies I; Woessmann W; Burkhardt B; Lisfeld J; Salzburg J; Janda A; Attarbaschi A; Niggli F; Zimmermann M; Reiter A; Klapper W
Br J Haematol; 2015 Mar; 168(6):835-44. PubMed ID: 25395120
[TBL] [Abstract][Full Text] [Related]
40. Short-pulse B-non-Hodgkin lymphoma-type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: a report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90.
Seidemann K; Tiemann M; Schrappe M; Yakisan E; Simonitsch I; Janka-Schaub G; Dörffel W; Zimmermann M; Mann G; Gadner H; Parwaresch R; Riehm H; Reiter A
Blood; 2001 Jun; 97(12):3699-706. PubMed ID: 11389005
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
